A Cohort Study of Bioabsorbable Screws for Syndesmosis Fixation Fixation in Ankle Fracture
Synfix
1 other identifier
observational
40
1 country
1
Brief Summary
The investigators aim to evaluate the fixation of the ankle syndesmosis in appropriate ankle fractures with bioabsorbable screws. Ankle fractures are common, and a proportion of them involve both fracture of the bone and also disruption of the syndesmosis, a strong ligamentous complex connecting the distal fibula and tibia. If left without fixation this causes a high incidence of pain and early arthritis. The most common technique for fixation of this syndesmosis involves the use of the same type of metal screws used to fix the fractured bones. As the syndesmosis permits small degrees of movement in normal subjects, fixation of this with metal usually leads to screw breakage and, or pain. It is common practice to remove these screws after a period of time once the syndesmosis has healed in the correct position. Bioabsorbable screws have the advantage of allowing small increments of movement, and also resorb naturally therefore do not have to be removed with a second surgical procedure. They are used in other centres worldwide, and the investigators therefore seek to evaluate syndesmosis fixation with them in their unit. The investigators would aim to recruit patients who have a syndesmotic injury requiring fixation, and who can consent to participating. They would undergo an identical surgical procedure to the standard current practice, apart from using a bioabsorbable screw in exchange for the metallic screw for syndesmosis fixation. All other components would remain unchanged, as would post operative protocol and management. To evaluate the fixation the investigators would use a limited CT scan (equivalent of about 3 months background radiation) after the time of fixation and at one year. This will help to assess the maintenance of reduction of the syndesmosis with time. The investigators would also assess patient reported outcome measures and pain scores, length of procedure and intraoperative radiation levels, weight bearing distribution tests, as well as any complication that may arise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2021
CompletedStudy Start
First participant enrolled
April 1, 2021
CompletedFirst Posted
Study publicly available on registry
December 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedDecember 22, 2022
December 1, 2022
3.8 years
March 8, 2021
December 14, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Computerised Tomography (CT) scan syndesmosis
All patients will undergo focused CT scanning two weeks post operatively and at one year. A customised foot holding device will enable to scan to be taken with both feet in neutral alignment (Evolution supine foot positioner, Vasocare Ltd). Assessment will be made in comparison with the contralateral side to assess reduction of the syndesmosis. Quantitive measurement of reduction will be measured using an established technique from the paper cited below in references.
Change in reduction between 2 weeks and 1 year post operatively
Secondary Outcomes (9)
Surgical Duration
Intraoperative
X- Ray (XR) Radiation exposure time and total dose
Intraoperative
Olerud-Molander Ankle Score (OMAS)
Pre-operative (baseline), 3 months, 6 months and 1 year post operatively. Absolute values measured as well as change in score over time intervals noted.
EQ5D3L (European Quality of Life 5 Dimensions 3 Level Version)
Pre-operative (baseline), 3 months, 6 months and 1 year post operatively.Absolute values measured as well as change in score over time intervals noted.
EQ-5D-3L VAS (European Quality of Life 5 Dimensions 3 Level Version) Health state
Pre-operative (baseline), 3 months, 6 months and 1 year post operatively.Absolute values measured as well as change in score over time intervals noted.
- +4 more secondary outcomes
Study Arms (1)
Ankle fracture with syndesmosis injury
Syndesmosis fixation using bioabsorbable screw
Interventions
as described prior
Eligibility Criteria
Meets above criteria with appropriate ankle fracture
You may qualify if:
- Patient has a Weber C fibula fracture with or without a medial malleolus fracture and evidence of radiological syndesmotic widening on intra-operative stressing
- Patient has a Weber B fracture with evidence of syndesmosis widening radiologically on stressing intra-operatively
- Patient has a maissoneuve type injury with evidence of syndesmotic diastasis
- Patient mobilises independently, with or without aids.
- Patient has given formal consent to be involved in the trial and has completed the study consent form
- Patient is likely to comply with study requirements
- Patient is over the age of 18 years and under 65 years
You may not qualify if:
- Immobility
- Presence of a posterior malleolus fracture involving \>25% of articular surface
- Open fractures
- Pathological fractures
- Other fractures involving the same lower extremity
- Patient unwilling to give informed consent to be included in the trial
- Patient has other injuries that would influence the study
- Any ankle fracture that the treating surgeon feels inappropriate to be included in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Grampianlead
Study Sites (1)
Aberdeen Royal Infirmary
Aberdeen, AB25 2ZN, United Kingdom
Related Publications (1)
Phisitkul P, Ebinger T, Goetz J, Vaseenon T, Marsh JL. Forceps reduction of the syndesmosis in rotational ankle fractures: a cadaveric study. J Bone Joint Surg Am. 2012 Dec 19;94(24):2256-61. doi: 10.2106/JBJS.K.01726.
PMID: 23318616BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alan Johnstone, MBChB FRCS
NHS Grampian
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2021
First Posted
December 22, 2022
Study Start
April 1, 2021
Primary Completion
December 31, 2024
Study Completion
July 1, 2025
Last Updated
December 22, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share